Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03893903
Title AMPLIFYing NEOepitope-specific VACcine Responses in Progressive Diffuse Glioma (AMPLIFY-NEOVAC)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors German Cancer Research Center
Indications

high grade glioma

Therapies

Avelumab

IDH1 R132H peptide vaccine

Avelumab + IDH1 R132H peptide vaccine

Age Groups: adult | senior
Covered Countries DEU

Additional content available in CKB BOOST